You are here

Stem cell transplants 'reverse early-stage MS'

Stem cell transplants 'reverse early-stage MS'
11th February 2009

The early stages of multiple sclerosis (MS) appear to reverse when transplanting the patient's own immune stem cells into their bodies, according to new research.

Chief of immunotherapy at Feinberg School Richard Burt, the principal investigator in the trial performed at Northwestern Memorial Hospital, found that such a practice seemed to "reset" the immune system of the sufferer.

Improvements were registered in areas such as walking, limb strength, incontinence and vision.

Commenting on the progress made in the study, Dr Burt said: "This is the first time we have turned the tide on this disease.

"What we did is promising and exiting but we need to prove it in a randomised trial."

The hospital is now undertaking a nationwide trial to see how the treatment affects different demographics in a variety of environments and climates.

Feinberg School of Medicine specialises in the development of primary and preventative care and is well known in the US for its work in the fields of acute lung injury, polycystic ovary syndrome and hematologic malignancies.

Please click here for advice to help you find the right type of care.